InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Conrad Herbert J, 董事. Officer active across 1 company, notably Matinas BioPharma Holdings, Inc.. Aggregated, 4 disclosures have been recorded. History available since 13 January 2021. The latest transaction was filed on 4 August 2021 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Conrad Herbert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
494,622 股0Common Stock, par value $0.0001 per shareSEC:0001493152-22-018581:0
1,280,917 股0Common Stock, par value $0.0001 per shareSEC:0001493152-21-016565:0
40,000 股0Common Stock, par value $0.0001 per shareSEC:0000905718-21-000824:0
50,000 股0Common Stock, par value $0.0001 per shareSEC:0001493152-21-012764:0
4 条申报中的 4 条
About Conrad Herbert J
Herbert J. Conrad is a Board Member at Matinas BioPharma Holdings, Inc. He is involved in overseeing the company's activities and in strategic decision-making. His role on the board allows him to provide valuable insights into governance and performance issues. Herbert helps ensure that decisions made are aligned with Matinas' strategic objectives.
